Literature DB >> 1957903

Influence of betaxolol and timolol on the visual fields of patients with glaucoma.

C Messmer1, J Flammer, D Stümpfig.   

Abstract

In a double-masked study, 40 patients with primary open-angle glaucoma were randomly assigned to treatment with betaxolol 0.5% or timolol 0.5% in both eyes twice daily. Visual fields and intraocular pressures were studied. Perimetry was performed with the Octopus G1 program two weeks after a washout period and three, six, 12, and 18 months after initiation of treatment. Both drugs reduced intraocular pressure. The reduction in intraocular pressure in the timolol-treated group was more pronounced than that in the betaxolol-treated group; the difference, however, was not statistically significant. In both treatment groups, the visual fields tended to improve during the first six months of treatment and remained stable or tended to deteriorate thereafter. The treatment effect on the visual field was better in the betaxolol-treated group than it was in the timolol-treated group (P = .041).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1957903     DOI: 10.1016/s0002-9394(14)77274-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  The effect of topical glaucoma medications evaluated by perimetry.

Authors:  J-C Lin; F Samuel; L J Katz; G L Spaeth; J Hoop; L B Cantor
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Effects of timolol on visual-field mean retinal sensitivity in normal subjects.

Authors:  X D Martin; F Fankhauser; P A Rabineau
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

Review 3.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Topical drug therapy in glaucoma.

Authors:  Hemma Resch; Gerhard Garhofer
Journal:  Wien Med Wochenschr       Date:  2006-09

5.  A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.

Authors:  P G Watson; M F Barnett; V Parker; J Haybittle
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

6.  Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.

Authors:  M Seki; T Tanaka; H Matsuda; T Togano; K Hashimoto; J Ueda; T Fukuchi; H Abe
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

Review 7.  Beta blockers and the elderly with glaucoma: are we adding insult to injury?

Authors:  E O'Donoghue
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

8.  Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

Review 9.  Management of glaucoma: focus on pharmacological therapy.

Authors:  Robert E Marquis; Jess T Whitson
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

10.  Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Authors:  Luciano Quaranta; Raffaele Turano; Teodoro Pizzolante
Journal:  Clin Ophthalmol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.